PETER KIM Lab Leader
As an M.I.T. professor, he researched proteins that block HIV from healthy cells. At Merck he spearheaded the company's 2001 acquisition of Rosetta InPharmatics, a biotech company. Kim, 44, was recently named head of Merck Research Laboratories, which spent approximately $3 billion last year. Among its products in late-stage development: treatments for depression, diabetes and chemotherapy-induced nausea, as well as a vaccine to prevent cervical cancer.
JUDY GIBBONS Portal Pusher
Born in an Irish farming village, Gibbons, 44, has landed near the top of Microsoft's Internet business. She has helped MSN, the company's Web-portal service, become Europe's...